WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattChairperson CEO2025-09-163,000$400.59
$1.20MSell
Martine A. RothblattChairperson CEO2025-09-161,000$399.28
$399.28kSell
Martine A. RothblattChairperson CEO2025-09-164,000$120.26
$481.04kBuy
Martine A. RothblattChairperson CEO2025-09-152,540$397.71
$1.01MSell
Martine A. RothblattChairperson CEO2025-09-151,460$398.19
$581.36kSell
Michael BenkowitzPRESIDENT AND COO2025-09-15820$397.96
$326.32kSell
Michael BenkowitzPRESIDENT AND COO2025-09-157,875$146.03
$1.15MBuy
Martine A. RothblattChairperson CEO2025-09-154,000$120.26
$481.04kBuy
Michael BenkowitzPRESIDENT AND COO2025-09-152,068$400.86
$828.97kSell
Michael BenkowitzPRESIDENT AND COO2025-09-152,289$400.24
$916.15kSell

1 of 62

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc11.79%5,333,708$2.12BInstitution
Lilly Co Eli11.61%5,251,394$2.09BInsider
Vanguard Group Inc9.84%4,448,848$1.77BInstitution
Avoro Capital Advisors LLC5.24%2,370,000$943.19MInstitution
State Street Corp4.79%2,167,511$862.60MInstitution
Renaissance Technologies LLC4.69%2,119,092$843.34MInstitution
Wellington Management Group LLP3.19%1,442,936$574.25MInstitution
Aqr Capital Management LLC2.82%1,273,161$506.68MInstitution
Geode Capital Management LLC2.65%1,200,365$477.71MInstitution
Invesco Ltd1.96%884,703$352.09MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.48%12.52%Net SellingNet Buying
GMAB99.31%0.00%
INCY77.48%22.52%Net SellingNet Selling
RPRX58.59%17.24%Net SellingNet Selling
SMMT7.22%92.78%Net BuyingNet Buying
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 96.95% institutional shareholders, 13.88% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.61% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.12B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.